MILD COGNITIVE IMPAIRMENT TREATMENT SECRETS

Learn more Satisfy our medical authorities Complement your knowledge with ours to improve test assortment and interpretation.No new safety signals were being noticed with ongoing lecanemab treatment. Following the initial six months, ARIA rates were similar to charges found with placebo, van Dyck and colleagues reported.Steerage documents, such as